Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Skin Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02048059
What this trial is testing

ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
Angiochem Inc 72
Early research (Phase 1)Ended earlyNCT00023790
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin

Who this might be right for
Breast CancerHead and Neck CancerLymphoma+3 more
Case Comprehensive Cancer Center 3
Early research (Phase 1)Study completedNCT02219789
What this trial is testing

Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Who this might be right for
Estrogen Receptor PositiveProgesterone Receptor PositiveRecurrent Breast Carcinoma+3 more
Mayo Clinic 10
Not applicableUnknownNCT00898690
What this trial is testing

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 120
Testing effectiveness (Phase 2)Study completedNCT00397579
What this trial is testing

DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesBlastic Plasmacytoid Dendritic Cell Neoplasm
University of Texas Southwestern Medical Center 11
Testing effectiveness (Phase 2)Study completedNCT00003989
What this trial is testing

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

Who this might be right for
Lung CancerMelanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 50
Testing effectiveness (Phase 2)Study completedNCT00005991
What this trial is testing

Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 76
Large-scale testing (Phase 3)Looking for participantsNCT04852887
What this trial is testing

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Who this might be right for
Stage I Breast Cancer
NRG Oncology 1,670
Large-scale testing (Phase 3)Looking for participantsNCT07062965
What this trial is testing

Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Who this might be right for
Breast Cancer
Pfizer 400
Testing effectiveness (Phase 2)Study completedNCT01783444
What this trial is testing

A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 309
Not applicableStudy completedNCT00828516
What this trial is testing

Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema

Who this might be right for
Breast CancerHead and Neck CancerLymphedema
East and North Hertfordshire NHS Trust 56
Testing effectiveness (Phase 2)Study completedNCT00654836
What this trial is testing

Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Loyola University 32
Testing effectiveness (Phase 2)Study completedNCT03890744
What this trial is testing

ModraDoc006/r in Patients With Breast Cancer

Who this might be right for
Metastatic Breast CancerRecurrent Breast Cancer
Modra Pharmaceuticals 12
Testing effectiveness (Phase 2)UnknownNCT04739670
What this trial is testing

Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer

Who this might be right for
Metastatic Triple Negative Breast Cancer
Peter MacCallum Cancer Centre, Australia 31
Testing effectiveness (Phase 2)Ended earlyNCT00003454
What this trial is testing

Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer

Who this might be right for
Stage IV Breast Cancer
Burzynski Research Institute 19
Large-scale testing (Phase 3)Looking for participantsNCT06839001
What this trial is testing

CRYoablation for Small Tumors As Local Treatment - SIX Trial

Who this might be right for
Breast CancerBreast Neoplasm
Hospital do Coracao 750
Large-scale testing (Phase 3)Study completedNCT00381901
What this trial is testing

Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Breast Cancer
National Cancer Institute, France 3,400
Testing effectiveness (Phase 2)Study completedNCT00101166
What this trial is testing

Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 43
Testing effectiveness (Phase 2)Study completedNCT00278070
What this trial is testing

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

Who this might be right for
Breast CancerNon Small Cell Lung CancerProstate Cancer
Hellenic Cooperative Oncology Group
Large-scale testing (Phase 3)Study completedNCT01492101
What this trial is testing

The BEACON Study (Breast Cancer Outcomes With NKTR-102)

Who this might be right for
Locally Recurrent Breast CancerMetastatic Breast Cancer
Nektar Therapeutics 852
Next Page